Document is current
Any future updates will be listed below
-
Authors
Simmons, Daniel
White, John
Walker, Valery
Blank, Stephanie V.
Munley, Jiefen
McLaurin, Kimmie
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 10 March 2025
First Online: 7 April 2025
Declarations
:
: Daniel Simmons, Jiefen Munley, and Kimmie McLaurin are employees of AstraZeneca. John White and Valery Walker are employees of Optum, which received funding from AstraZeneca to conduct this study. Stephanie Blank has received grant support through the NCI and serves on the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology.
: The study protocol was reviewed and approved by the New England Institutional Review Board (15 June 2020, #20201707). The study obtained a waiver of informed consent and a waiver of authorization under 45 CFR 164.512(i).
